Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist
- 1 July 1985
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 337 (2), 352-356
- https://doi.org/10.1016/0006-8993(85)90074-5
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education
This publication has 11 references indexed in Scilit:
- Effects of β-neo-endorphin on behaviors in mice using multi-dimensional behavioral analysesPeptides, 1984
- Naloxone reverses the inhibitory effects of dynorphin A on motor activity in the mousePharmacology Biochemistry and Behavior, 1984
- The antagonistic effects of naloxone on hypermotility in mice induced by dynorphin-(1-13) using a multi-dimensional behavioral analysisNeuropharmacology, 1984
- Multi-dimensional analyses of behavior in mice treated with morphine, endorphins and [des-tyrosine1]-γ-endorphinPharmacology Biochemistry and Behavior, 1983
- Effects of opiate antagonists and putative mu- and kappa-agonists on milk intake in rat and squirrel monkeyPharmacology Biochemistry and Behavior, 1982
- Properties of a selective kappa agonist, U-50,488HLife Sciences, 1982
- U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouseLife Sciences, 1982
- U-50,488, a selective kappa opioid agonist: Comparison to other reputed kappa agonistsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- Discriminative stimulus properties of bremazocine in the ratNeuropharmacology, 1981
- Bremazocine: A potent, long-acting opiate kappa-agonistLife Sciences, 1980